EUVIMEDEUVIMED entdecken
Crossref

Vitexin mitigates oxidative stress, mitochondrial damage, pyroptosis and regulates small nucleolar RNA host gene 1/DNA methyltransferase 1/microRNA-495 axis in sepsis-associated acute lung injury

Almaz Zaki, Mohd Mohsin, Salman Khan, Aman Khan, Shaniya Ahmad, Amit Verma, Shakir Ali, Tasneem Fatma, Mansoor Ali Syed

Inflammopharmacology · 2025

DOI: 10.1007/s10787-024-01609-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammopharmacology, 2025. Verfasst von Almaz Zaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Lab, Srinivas Ramanujan Block, Department of Biotechnology, Faculty of Life Sciences, Jamia Millia Islamia, New Delhi, 110025,…. Hauptthemen laut MEDLINE: Sepsis, Acute Lung Injury, Pyroptosis, MicroRNAs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: The Science and Engineering Research Board, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM OF THE STUDY: This study examined vitexin's effect on sepsis-induced acute lung injury. We used network pharmacology and in vivo and in vitro experiments were performed to elucidate vitexin's role in preventing pyroptosis and regulating small nucleolar RNA host gene 1 (SNHG1)/DNA methyltransferase 1 (DNMT1)/microRNA-495 (miR-495 axis. MATERIALS AND METHODS: We developed an acute lung injury model using C57BL/6 mice and MLE-12 cells. Through a combination of network pharmacology and in vitro screening, vitexin was identified as the most promising anti-inflammatory compound. Multiple techniques such as western blotting, real-time PCR, Hematoxylin and eosin staining, immunohistochemistry, and TUNEL assay were used. Additionally, immunofluorescence, DCFDA and TMRE staining, flow cytometry, methylation-specific PCR, and gene transfection techniques were performed to elucidate vitexin's potential targets and underlying mechanisms. RESULTS: Vitexin treatment significantly reduced lung damage, neutrophil infiltration, and inflammation while improving tight junction integrity. In LPS-treated RAW264.7 macrophages and a septic mouse BALF-induced MLE-12 cell injury model, vitexin demonstrated anti-inflammatory effects, promoted M2 macrophage polarization, and enhanced regenerative markers. It also decreased oxidative stress, mitigated apoptosis and pyroptosis, and improved mitochondrial function. Our research uncovered a novel epigenetic regulatory mechanism involving lncRNA SNHG1, DNMT1, and miR-495. CONCLUSION: Vitexin's ability to reduce inflammation, counteract oxidative stress, and modulate epigenetic processes. These findings underscore the promising role of vitexin as a treatment for ALI generated by sepsis. The SNHG1/miR-495 axis, which has been identified, represents a new target for future therapies in acute lung injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisAcute Lung InjuryPyroptosisMicroRNAsApigeninOxidative StressAnimalsMiceMice, Inbred C57BLDNA (Cytosine-5-)-Methyltransferase 1MaleMitochondriaRAW 264.7 CellsRNA, Long NoncodingDisease Models, Animal

Stichwörter der Autor:innen

Acute Lung InjuryInflammationMitochondriaNoncoding RNASepsis

Substanzen

MicroRNAsApigeninDNA (Cytosine-5-)-Methyltransferase 1vitexinRNA, Long NoncodingDnmt1 protein, mouse

Autor:innen und Institutionen

  • Translational Research Lab, Srinivas Ramanujan Block, Department of Biotechnology, Faculty of Life Sciences, Jamia Millia Islamia, New Delhi, 110025, India.
  • Department of Biosciences, Faculty of Life Sciences, Jamia Millia Islamia, New Delhi, India.
  • Division of Diagnostic Innovation, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard University, New Delhi, India.
  • Translational Research Lab, Srinivas Ramanujan Block, Department of Biotechnology, Faculty of Life Sciences, Jamia Millia Islamia, New Delhi, 110025, India. smansoor@jmi.ac.in.

Förderung

  • The Science and Engineering Research Board
  • Indian Council of Medical Research

Zitieren

APA

Zaki, A., Mohsin, M., Khan, S., Khan, A., Ahmad, S., Verma, A., Ali, S., Fatma, T., & Syed, M. A. (2025). Vitexin mitigates oxidative stress, mitochondrial damage, pyroptosis and regulates small nucleolar RNA host gene 1/DNA methyltransferase 1/microRNA-495 axis in sepsis-associated acute lung injury. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01609-6

Vancouver

Zaki A, Mohsin M, Khan S, Khan A, Ahmad S, Verma A, et al. Vitexin mitigates oxidative stress, mitochondrial damage, pyroptosis and regulates small nucleolar RNA host gene 1/DNA methyltransferase 1/microRNA-495 axis in sepsis-associated acute lung injury. Inflammopharmacology. 2025. doi:10.1007/s10787-024-01609-6

BibTeX
@article{Zaki2025,
  author = {Zaki, Almaz and Mohsin, Mohd and Khan, Salman and Khan, Aman and Ahmad, Shaniya and Verma, Amit and Ali, Shakir and Fatma, Tasneem and Syed, Mansoor Ali},
  title = {Vitexin mitigates oxidative stress, mitochondrial damage, pyroptosis and regulates small nucleolar RNA host gene 1/DNA methyltransferase 1/microRNA-495 axis in sepsis-associated acute lung injury},
  journal = {Inflammopharmacology},
  year = {2025},
  doi = {10.1007/s10787-024-01609-6}
}
Kostenlos starten →